Diplomat Pharmaceuticals: 2Q Earnings Snapshot
Aug. 06, 2018
FLINT, Mich. (AP) _ Diplomat Pharmacy Inc. (DPLO) on Monday reported a second-quarter loss of $4 million, after reporting a profit in the same period a year earlier.
The Flint, Michigan-based company said it had a loss of 5 cents per share. Earnings, adjusted for one-time gains and costs, came to 17 cents per share.
The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 23 cents per share.
The independent specialty pharmacy posted revenue of $1.42 billion in the period, meeting Street forecasts.
Diplomat Pharmaceuticals expects a full-year loss of 15 cents to 1 cent per share, with revenue in the range of $5.5 billion to $5.9 billion.
Diplomat Pharmaceuticals shares have risen nearly 7 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $21.46, an increase of 45 percent in the last 12 months.